KMT2A and leukemia: In MLL-AF9 (MA9) leukaemia mice, KD of Rbfox2 greatly inhibited colony-forming capacity of leukaemic bone marrow blast cells, reduced LSC population and promoted their differentiation (Extended Data Fig. 7c–h), suggesting RBFOX2 is required for LSC/LIC maintenance.